Day Zero Diagnostics Bloodstream Infection Test
Provider 
Founded 2016
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Venture-backed

Day Zero Diagnostics offers a sequencing-based test identifying bloodstream pathogens and resistance markers directly from whole blood without culture.
Day Zero Diagnostics is developing a sequencing-based diagnostic that analyzes bacterial DNA directly from a patient whole-blood sample without time-consuming culture, pairing ultra-high-enrichment sample preparation with Keynome identification algorithms to report pathogen identity and predicted resistance.
The approach targets bloodstream infections and sepsis workups where Karius Spectrum is ordered, offering species identification and resistance profiling within hours to support earlier targeted antimicrobial therapy.
| Attribute | Day Zero Diagnostics Bloodstream Infection Test | Karius Spectrum | |
|---|---|---|---|
| Provider | |||
| Founded | 2016 | 2014 | |
| Sells To | Enterprise | Enterprise | |
| Pricing Model | Recurring, Software | Recurring, Software | |
| Ownership | Venture-backed | Private, Venture-backed |
Provider 
Founded 2016
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Venture-backed
Provider 
Founded 2014
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Private, Venture-backed


Karius Focus BAL is a BAL-fluid microbial cell-free DNA sequencing test detecting 500+ pathogens causing lung infections.


Delve Detect is a metagenomic sequencing test identifying infections in under 48 hours.
DISQVER is a metagenomic sequencing platform identifying bloodstream pathogens from blood cell-free DNA within 24 hours.

Karius Focus BAL is a BAL-fluid microbial cell-free DNA sequencing test detecting 500+ pathogens causing lung infections.

Delve Detect is a metagenomic sequencing test identifying infections in under 48 hours.
